Company Filing History:
Years Active: 2019
Title: Eva Bonzli: Innovator in Feline Leukemia Diagnosis
Introduction
Eva Bonzli is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of veterinary medicine, particularly in the diagnosis of feline leukemia virus (FeLV) infections. Her innovative work has the potential to improve the health and well-being of cats worldwide.
Latest Patents
Eva Bonzli holds 1 patent for her invention titled "Feline leukemia virus trans-membrane protein p15E for diagnosis of FeLV infection." This invention provides a method for detecting FeLV infection in a patient. The process involves contacting a sample obtained from the patient in vitro with a recombinant transmembrane p15E protein during a p15 (E) antibody binding step. This advancement is crucial for timely diagnosis and treatment of affected felines.
Career Highlights
Eva Bonzli is affiliated with the Universität Zürich, where she conducts her research and develops her innovative solutions. Her work has garnered attention in the scientific community, showcasing her dedication to advancing veterinary diagnostics.
Collaborations
Eva collaborates with esteemed colleagues such as Hans Lutz and Regina Hofmann-Lehmann. Their combined expertise enhances the research and development of effective diagnostic methods for feline health.
Conclusion
Eva Bonzli's contributions to the field of veterinary medicine through her innovative patent demonstrate her commitment to improving feline health. Her work is a testament to the impact of dedicated inventors in advancing medical diagnostics.